[1]
Parmar, A. et al. 2021. Development of a radiomic signature for predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Canadian Urological Association Journal. 16, 3 (Oct. 2021), E113–9. DOI:https://doi.org/10.5489/cuaj.7294.